Linden Thomas Advisory Services’s NovoCure NVCR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-13,126	Closed	-$205K	–	472
2024 Q1	$205K	Buy	13,126 +89	+0.7%	+$1.39K	0.03%	439
2023 Q4	$195K	Buy	13,037 +88	+0.7%	+$1.31K	0.04%	411
2023 Q3	$209K	Buy	+12,949	New	+$209K	0.05%	374